News

Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally

BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ -- Lyfegen, a global leader in drug rebate management technology, today announced…

1 year ago

Regulation of AI in Healthcare

WASHINGTON, Dec. 11, 2024 /PRNewswire/ -- Paragon Health Institute, a leader in healthcare research and market-based policy proposals, has released…

1 year ago

UK Clinicians Call for Urgent Modernization of NHS EHR Systems to Align With Global Healthcare IT Advancements, Black Book Survey Finds

The 2025 Black Book of Global Healthcare IT user polls reveal a critical need to modernize NHS EHR systems to…

1 year ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 – January 30, 2025

STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ:ACXP), a late-stage…

1 year ago

Belhaven Biopharma Set to Unveil Promising Nasdepi(R) Data at DDL 2024

Dry Powder Epinephrine Product Demonstrates Reliable and Consistent Delivery in Real-World Dosing Situations with a Heat-Stable Formulation RALEIGH, NC /…

1 year ago

Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces…

1 year ago

Therma Bright Congratulates Investment Partner Inretio’s Promising Initial Results from PREVA(TM) Device’s First Clinical Phase

Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, 2024) -…

1 year ago

Clearstep Chosen to Provide the AI-Powered Smart Routing Engine for the Defense Health Agency’s New Digital Front Door

Clearstep's Smart Access solution will serve as a cornerstone of the Digital Front Door program, intended to modernize military healthcare…

1 year ago

CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas

Target Acquisition Valued at $10 Million with Projected 2025 Gross Revenue of $5 Million, Positioning CBDL for Explosive Growth in…

1 year ago

New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry

LOS ANGELES, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for…

1 year ago